DSM-Firmenich AG

BMV:DSM N Rapport sur les actions

Capitalisation boursière : Mex$14.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

DSM-Firmenich Résultats passés

Passé contrôle des critères 1/6

DSM-Firmenich's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings growing at 20.5% annually. Revenues have been declining at an average rate of 0.8% per year. DSM-Firmenich's return on equity is 4.4%, and it has net margins of 5.4%.

Informations clés

-20.7%

Taux de croissance des bénéfices

-20.2%

Taux de croissance du BPA

Chemicals Croissance de l'industrie13.1%
Taux de croissance des recettes-0.8%
Rendement des fonds propres4.4%
Marge nette5.4%
Prochaine mise à jour des résultats02 Aug 2023

Mises à jour récentes des performances passées

Recent updates

Ventilation des recettes et des dépenses

Comment DSM-Firmenich gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

BMV:DSM N Recettes, dépenses et bénéfices (EUR Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Dec 228,3904541,772295
30 Sep 229,582837895162
30 Jun 229,8021,0821,789323
31 Mar 229,5031,0811,789323
31 Dec 217,2698201,649274
30 Sep 217,9556602,517560
30 Jun 217,5584931,622398
31 Mar 217,5724231,622398
31 Dec 208,1064481,622398
30 Sep 207,9605101,639295
30 Jun 208,0345571,639295
31 Mar 209,0117221,795349
31 Dec 197,9986751,639295
30 Sep 198,2728201,839348
30 Jun 198,5027941,839348
31 Mar 199,1249341,839348
31 Dec 189,2671,0691,839348
30 Sep 189,2359841,753334
30 Jun 189,1062,0821,753334
31 Mar 188,9081,9421,753334
31 Dec 178,6321,7611,753334
30 Sep 178,4711,6761,694309
30 Jun 178,3337381,694309
31 Mar 178,1667111,694309
31 Dec 167,9206451,694309
30 Sep 167,8315881,605332
30 Jun 167,7782741,605332
31 Mar 167,7492141,605332
31 Dec 157,7221741,605332
30 Sep 157,607661,382304
30 Jun 157,4561141,382304
31 Mar 157,2451151,382304
31 Dec 147,0511231,382304
30 Sep 147,4151121,430340
30 Jun 147,8341381,430340
31 Mar 148,3621821,430340
31 Dec 138,8582521,430340
30 Sep 138,4093631,396372
30 Jun 138,5003351,396372
31 Mar 138,4862571,396372
31 Dec 128,5882801,396372
30 Sep 129,0894531,356378
30 Jun 129,1075431,356378

Des revenus de qualité: DSM N has high quality earnings.

Augmentation de la marge bénéficiaire: DSM N's current net profit margins (5.4%) are lower than last year (11.3%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: DSM N's earnings have declined by 20.7% per year over the past 5 years.

Accélération de la croissance: DSM N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Bénéfices par rapport au secteur d'activité: DSM N had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (-12.7%).

Rendement des fonds propres

ROE élevé: DSM N's Return on Equity (4.4%) is considered low.

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y